本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

enVVeno Medical Corp.

0.3843
-0.0357-8.50%
成交量:165.25萬
成交額:63.36萬
市值:776.91萬
市盈率:-0.36
高:0.3964
開:0.3700
低:0.3600
收:0.4200
52周最高:5.62
52周最低:0.3600
股本:2,021.62萬
流通股本:1,908.56萬
量比:2.99
換手率:8.66%
股息:- -
股息率:- -
每股收益(TTM):-1.0815
每股收益(LYR):-1.2728
淨資產收益率:-57.19%
總資產收益率:-35.12%
市淨率:0.26
市盈率(LYR):-0.30

資料載入中...

2024/05/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

重要事件披露

Form 8-K - Current report
2024/03/06

重要事件披露

Form 8-K - Current report
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/23

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/16

重要事件披露

Form 8-K - Current report
2023/11/02

SEC問詢函

Form CORRESP - Correspondence
2023/10/26

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/12

重要事件披露

Form 8-K - Current report
2023/08/22

SEC問詢函

Form CORRESP - Correspondence
2023/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/26

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/04/28

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/02

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report